Valneva SE (VALN) Net Shares Issued and Repurchased (2021 - 2026)

Valneva SE (VALN) posted Net Shares Issued and Repurchased of $1.1 million for Q1 2026, down 84.93% sequentially from $7.1 million in Q3 2025.

Valneva SE (VALN) Net Shares Issued and Repurchased (2021 - 2026) Analysis & Trends

Valneva SE has reported Net Shares Issued and Repurchased for 6 years, with the latest figure at $1.1 million in Q1 2026.

  • Quarterly Net Shares Issued and Repurchased changed N/A year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.0 million (down 50.58% YoY) and the FY2024 annual result came in at $61.8 million, up 23921.58% from the prior year.
  • Net Shares Issued and Repurchased retreated to $1.1 million in Q1 2026 per VALN's latest filing, from $7.1 million in the prior quarter.
  • Over five years, Net Shares Issued and Repurchased peaked at $310.0 million in Q3 2023 and troughed at -$310.1 million in Q2 2023.
  • A 5-year average of $31.9 million and a median of $7.1 million in 2025 frame the typical range for Net Shares Issued and Repurchased.
  • The sharpest annual moves came in 2024 and 2025: Net Shares Issued and Repurchased slumped 79.64% in 2024, then sank 88.68% in 2025.
  • Over 5 years, Net Shares Issued and Repurchased stood at $193.7 million in 2022, then surged by 60.05% to $310.0 million in 2023, then slumped by 100.11% to -$343019.1 in 2024, then jumped by 2183.05% to $7.1 million in 2025, then sank by 84.93% to $1.1 million in 2026.
  • According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $1.1 million, $7.1 million, and $22.8 million for Q1 2026, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Valneva SE 618.67 Mn 477.41 Mn 1.86 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.08 Mn
Mar 31, 2026 1.08 Mn
Sep 30, 2025 7.15 Mn
Sep 30, 2025 7.15 Mn
Jun 30, 2025 22.79 Mn
Jun 30, 2025 22.79 Mn
Dec 31, 2024 -343,019.12
Dec 31, 2024 -343,019.12
Sep 30, 2024 63.10 Mn
Sep 30, 2024 63.10 Mn
Sep 30, 2023 309.99 Mn
Sep 30, 2023 309.99 Mn
Jun 30, 2023 -310.13 Mn
Jun 30, 2023 -310.13 Mn
Mar 31, 2023 -208,228.31
Mar 31, 2023 -208,228.31
Dec 31, 2022 193.68 Mn
Dec 31, 2022 193.68 Mn
Mar 31, 2021 185,760.36
Mar 31, 2021 185,760.36